Journal article

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

The burden of invasive pneumococcal disease in young children decreased dramatically following introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). The epidemiology of S. pneumoniae now reflects infections caused by serotypes not included in PCV7. Recently introduced higher valency pneumococcal vaccines target the residual burden of invasive and non-invasive infections, including those caused by serotypes not included in PCV7. This review is based on presentations made at the European Society of Pediatric Infectious Diseases in June 2011.

Languages

  • English

Journal

BMC Infectious Diseases

Volume

207

Type

Journal article

Categories

  • Vaccines & delivery devices